4.0 Review

The Relation of Type 2 Diabetes and Breast Cancer Incidence in Asian, Hispanic and African American Populations-A Review

Journal

CANADIAN JOURNAL OF DIABETES
Volume 42, Issue 1, Pages 100-105

Publisher

ELSEVIER
DOI: 10.1016/j.jcjd.2017.02.005

Keywords

African American; Asian; breast cancer; Hispanic; review; type 2 diabetes

Ask authors/readers for more resources

In addition to rising type 2 diabetes and breast cancer incidence rates worldwide, diabetes may also increase breast cancer risk, and the association may vary by ethnicity. This review summarizes published data evaluating the association between diabetes and breast cancer in women of Asian, Hispanic and African American ancestry while considering a measure of obesity, body mass index (BMI). Published reports were identified through a search of PubMed and previous publications. Of 15 age-adjusted studies, 11 reported on Asian women from various countries, 3 on Hispanics and 1 on African Americans. The studies of Asian women described significant associations in 8 reports, with risk estimates of 1.5 to 8.4, but 3 were case-control studies and 6 did not adjust for BMI. The 3 case-control studies of Hispanic people included BMI, but only 1 detected a weak association between diabetes and breast cancer risk and was limited to postmenopausal women. The only study of African American women was a prospective cohort, and it showed no significant association between diabetes and breast cancer. In contrast to a 10% to 20% higher risk for breast cancer associated with diabetes reported for Caucasian women, there is little evidence for an association in Hispanics and African Americans. Although several studies of Asian women included in our review reported a higher risk for breast cancer with diabetes, methodologic shortcomings, such as lack of adjustment for obesity, use of a general population as controls, case-control design and small sample sizes, raise questions about the validity of the findings. (C) 2017 Canadian Diabetes Association.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Obstetrics & Gynecology

Perioperative opioid-prescribing practices of resident trainees compared with staff surgeons

Ally Murji, Lucie Richard, Eric McArthur, Peter C. Austin, Lorraine Lipscombe, Tara Gomes

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Article Oncology

Periodic screening for breast and cervical cancer in women with diabetes: a population-based cohort study

Dominika Bhatia, Rinku Sutradhar, Peter C. Austin, Vasily Giannakeas, Liisa Jaakkimainen, Lawrence F. Paszat, Lorraine L. Lipscombe

Summary: The study found that women with diabetes are less likely to undergo periodic screenings for breast and cervical cancer. The impact of diabetes on cervical cancer screening is particularly significant, suggesting a need for increased attention to cervical cancer prevention services in women with diabetes.

CANCER CAUSES & CONTROL (2022)

Article Environmental Sciences

Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana

Ashley M. Geczik, Roni T. Falk, Xia Xu, Beatrice Wiafe-Addai, Joel Yarney, Baffour Awuah, Richard Biritwum, Verna Vanderpuye, Florence Dedey, Ernest Adjei, Francis Aitpillah, Ernest Osei-Bonsu, Joseph Oppong, Nicholas Titiloye, Lawrence Edusei, Kofi Nyarko, Joe-Nat Clegg-Lamptey, Seth Wiafe, Daniel Ansong, Thomas U. Ahearn, Jonine Figueroa, Montserrat Garcia-Closas, Louise A. Brinton, Britton Trabert

Summary: This study provides evidence that the use of lye-based hair relaxer products may increase circulating levels of 16-pathway estrogens, particularly estriol and 16-epiestriol. Additionally, scalp burns among hair relaxer users were associated with elevated levels of unconjugated estrogens. However, no association was found between the use of skin lighteners and estrogen metabolism.

JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY (2023)

Correction Environmental Sciences

Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana (Jan, 10.1038/s41370-021-00407-4, 2022)

Ashley M. Geczik, Roni T. Falk, Xia Xu, Beatrice Wiafe-Addai, Joel Yarney, Baffour Awuah, Richard Biritwum, Verna Vanderpuye, Florence Dedey, Ernest Adjei, Francis Aitpillah, Ernest Osei-Bonsu, Joseph Oppong, Nicholas Titiloye, Lawrence Edusei, Kofi Nyarko, Joe-Nat Clegg-Lamptey, Seth Wiafe, Daniel Ansong, Thomas U. Ahearn, Jonine Figueroa, Montserrat Garcia-Closas, Louise A. Brinton, Britton Trabert

JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY (2023)

Article Medicine, General & Internal

Healthy food prescription incentive programme for adults with type 2 diabetes who are experiencing food insecurity: protocol for a randomised controlled trial, modelling and implementation studies

Dana Lee Olstad, Reed Beall, Eldon Spackman, Sharlette Dunn, Lorraine L. Lipscombe, Kienan Williams, Richard Oster, Sara Scott, Gabrielle L. Zimmermann, Kerry A. McBrien, Kieran J. D. Steer, Catherine B. Chan, Sheila Tyminski, Seth Berkowitz, Alun L. Edwards, Terry Saunders-Smith, Saania Tariq, Naomi Popeski, Laura White, Tyler Williamson, Mary L'Abbe, Kim D. Raine, Sara Nejatinamini, Aruba Naser, Carlota Basualdo-Hammond, Colleen Norris, Petra O'Connell, Judy Seidel, Richard Lewanczuk, Jason Cabaj, David J. T. Campbell

Summary: This study aims to explore the effectiveness and implementation of a healthy food prescription incentive program for adults with food insecurity and high blood glucose levels. The study includes methods such as randomized controlled trials, modeling studies, and implementation studies to evaluate the program's impact on blood glucose levels, diet quality, and other clinical outcomes. The findings of this study will be disseminated through various channels.

BMJ OPEN (2022)

Article Oncology

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

Nasim Mavaddat, Leila Dorling, Sara Carvalho, Jamie Allen, Anna Gonzalez-Neira, Renske Keeman, Manjeet K. Bolla, Joe Dennis, Qin Wang, Thomas U. Ahearn, Irene L. Andrulis, Matthias W. Beckmann, Sabine Behrens, Javier Benitez, Marina Bermisheva, Carl Blomqvist, Natalia Bogdanova, Stig E. Bojesen, Ignacio Briceno, Thomas Bruning, Nicola J. Camp, Archie Campbell, Jose E. Castelao, Jenny Chang-Claude, Stephen J. Chanock, Georgia Chenevix-Trench, Hans Christiansen, Kamila Czene, Thilo Dork, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Marike Gabrielson, Manuela Gago-Dominguez, Jurgen Geisler, Graham G. Giles, Pascal Guenel, Andreas Hadjisavvas, Eric Hahnen, Per Hall, Ute Hamann, Jaana M. Hartikainen, Mikael Hartman, Reiner Hoppe, Anthony Howell, Anna Jakubowska, Audrey Jung, Elza K. Khusnutdinova, Vessela N. Kristensen, Jingmei Li, Swee Ho Lim, Annika Lindblom, Maria A. Loizidou, Artitaya Lophatananon, Jan Lubinski, Michael J. Madsen, Arto Mannermaa, Mehdi Manoochehri, Sara Margolin, Dimitrios Mavroudis, Roger L. Milne, Nur Aishah Mohd Taib, Anna Morra, Kenneth Muir, Nadia Obi, Ana Osorio, Tjoung-Won Park-Simon, Paolo Peterlongo, Paolo Radice, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Mitul Shah, Xueling Sim, Melissa C. Southey, Heather Thorne, Ian Tomlinson, Diana Torres, Therese Truong, Cheng Har Yip, Amanda B. Spurdle, Maaike P. G. Vreeswijk, Alison M. Dunning, Montserrat Garcia-Closas, Paul D. P. Pharoah, Anders Kvist, Taru A. Muranen, Heli Nevanlinna, Soo Hwang Teo, Peter Devilee, Marjanka K. Schmidt, Douglas F. Easton

Summary: This case-control study analyzed breast cancer susceptibility genes and found that they are associated with different breast cancer subtypes and tumor characteristics. Understanding the age and subtype distributions associated with each gene can guide gene panel testing, risk prediction, and screening strategies.

JAMA ONCOLOGY (2022)

Article Oncology

Platelet Count and Survival after Cancer

Vasily Giannakeas, Joanne Kotsopoulos, Jennifer D. Brooks, Matthew C. Cheung, Laura Rosella, Lorraine Lipscombe, Mohammad R. Akbari, Peter C. Austin, Steven A. Narod

Summary: Research shows that platelet count in cancer patients is associated with survival rates, with higher counts correlating with poorer survival and lower counts with better survival. Platelet count could potentially serve as a risk assessment measure for cancer patients.

CANCERS (2022)

Article Medicine, General & Internal

Analysis of Platelet Count and New Cancer Diagnosis Over a 10-Year Period

Vasily Giannakeas, Joanne Kotsopoulos, Matthew C. Cheung, Laura Rosella, Jennifer D. Brooks, Lorraine Lipscombe, Mohammad R. Akbari, Peter C. Austin, Steven A. Narod

Summary: Elevated platelet count is associated with increased risk of cancer at multiple sites, but the odds ratios decrease with time from CBC test to cancer diagnosis. The findings suggest that elevated platelet count could potentially serve as a marker for certain types of cancer.

JAMA NETWORK OPEN (2022)

Article Biology

Rare germline copy number variants (CNVs) and breast cancer risk

Joe Dennis, Jonathan P. Tyrer, Logan C. Walker, Kyriaki Michailidou, Leila Dorling, Manjeet K. Bolla, Qin Wang, Thomas U. Ahearn, Irene L. Andrulis, Hoda Anton-Culver, Natalia N. Antonenkova, Volker Arndt, Kristan J. Aronson, Laura E. Beane Freeman, Matthias W. Beckmann, Sabine Behrens, Javier Benitez, Marina Bermisheva, Natalia Bogdanova, Stig E. Bojesen, Hermann Brenner, Jose E. Castelao, Jenny Chang-Claude, Georgia Chenevix-Trench, Christine L. Clarke, J. Margriet Collee, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Peter Devilee, Thilo Dork, Laure Dossus, A. Heather Eliassen, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Jonine Figueroa, Olivia Fletcher, Henrik Flyger, Lin Fritschi, Marike Gabrielson, Manuela Gago-Dominguez, Montserrat Garcia-Closas, Graham G. Giles, Anna Gonzalez-Neira, Pascal Guenel, Eric Hahnen, Christopher A. Haiman, Per Hall, Antoinette Hollestelle, Reiner Hoppe, John L. Hopper, Anthony Howell, Agnes Jager, Anna Jakubowska, Esther M. John, Nichola Johnson, Michael E. Jones, Audrey Jung, Rudolf Kaaks, Renske Keeman, Elza Khusnutdinova, Cari M. Kitahara, Yon-Dschun Ko, Veli-Matti Kosma, Stella Koutros, Peter Kraft, Vessela N. Kristensen, Katerina Kubelka-Sabit, Allison W. Kurian, James Lacey, Diether Lambrechts, Nicole L. Larson, Martha Linet, Alicja Ogrodniczak, Arto Mannermaa, Siranoush Manoukian, Sara Margolin, Dimitrios Mavroudis, Roger L. Milne, Taru A. Muranen, Rachel A. Murphy, Heli Nevanlinna, Janet E. Olson, Hakan Olsson, Tjoung-Won Park-Simon, Charles M. Perou, Paolo Peterlongo, Dijana Plaseska-Karanfilska, Katri Pylkas, Gad Rennert, Emmanouil Saloustros, Dale P. Sandler, Elinor J. Sawyer, Marjanka K. Schmidt, Rita K. Schmutzler, Rana Shibli, Ann Smeets, Penny Soucy, Melissa C. Southey, Anthony J. Swerdlow, Rulla M. Tamimi, Jack A. Taylor, Lauren R. Teras, Mary Beth Terry, Ian Tomlinson, Melissa A. Troester, Therese Truong, Celine M. Vachon, Camilla Wendt, Robert Winqvist, Alicja Wolk, Xiaohong R. Yang, Wei Zheng, Argyrios Ziogas, Jacques Simard, Alison M. Dunning, Paul D. P. Pharoah, Douglas F. Easton

Summary: This study investigates the potential associations between rare germline copy number variants (CNVs) and breast cancer using a genome-wide analysis in a large breast cancer case-control dataset. The study identifies associations between exonic deletions in established breast cancer susceptibility genes and suggests potential associations for non-coding CNVs in both known and novel loci with large effects sizes.

COMMUNICATIONS BIOLOGY (2022)

Article Endocrinology & Metabolism

Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study

Wajd Alkabbani, Colleen J. Maxwell, Ruth Ann Marrie, Suzanne L. Tyas, Iliana C. Lega, John-Michael Gamble

Summary: This study reveals that both mid- and late-life hypoglycemia are associated with a doubled risk of dementia. Patients who experienced severe hypoglycemic events in mid- and late-life have a higher risk of developing dementia compared to those without hypoglycemia.

DIABETES CARE (2023)

Article Biochemistry & Molecular Biology

FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women

Gisella Figlioli, Amandine Billaud, Thomas U. Ahearn, Natalia N. Antonenkova, Heiko Becher, Matthias W. Beckmann, Sabine Behrens, Javier Benitez, Marina Bermisheva, Marinus J. Blok, Natalia Bogdanova, Bernardo Bonanni, Barbara Burwinkel, Nicola J. Camp, Archie Campbell, Jose E. Castelao, Melissa H. Cessna, Stephen J. Chanock, Kamila Czene, Peter Devilee, Thilo Doerk, Christoph Engel, Mikael Eriksson, Peter A. Fasching, Jonine D. Figueroa, Marike Gabrielson, Manuela Gago-Dominguez, Montserrat Garcia-Closas, Anna Gonzalez-Neira, Felix Grassmann, Pascal Guenel, Melanie Gundert, Andreas Hadjisavvas, Eric Hahnen, Per Hall, Ute Hamann, Patricia A. Harrington, Wei He, Peter Hillemanns, Antoinette Hollestelle, Maartje J. Hooning, Reiner Hoppe, Anthony Howell, Keith Humphreys, Agnes Jager, Anna Jakubowska, Elza K. Khusnutdinova, Yon-Dschun Ko, Vessela N. Kristensen, Annika Lindblom, Jolanta Lissowska, Jan Lubinski, Arto Mannermaa, Siranoush Manoukian, Sara Margolin, Dimitrios Mavroudis, William G. Newman, Nadia Obi, Mihalis Panayiotidis, Muhammad U. Rashid, Valerie Rhenius, Matti A. Rookus, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Mitul Shah, Reijo Sironen, Melissa C. Southey, Maija Suvanto, Rob A. E. M. Tollenaar, Ian Tomlinson, Therese Truong, Lizet E. van der Kolk, Elke M. van Veen, Barbara Wappenschmidt, Xiaohong R. Yang, Manjeet K. Bolla, Joe Dennis, Alison M. Dunning, Douglas F. Easton, Michael Lush, Kyriaki Michailidou, Paul D. P. Pharoah, Qin Wang, Muriel A. Adank, Marjanka K. Schmidt, Irene L. Andrulis, Jenny Chang-Claude, Heli Nevanlinna, Georgia Chenevix-Trench, D. Gareth Evans, Roger L. Milne, Paolo Radice, Paolo Peterlongo

Summary: Evidence from the BRIDGES study suggests that germline protein truncating variants (PTVs) in FANCM are associated with increased risk of ER-negative and triple-negative breast cancer (TNBC), particularly for those with a family history. This study further investigates the association between FANCM missense variants (MVs) and breast cancer risk using the BRIDGES study, analyzing a total of 689 MVs. The results indicate that FANCM MVs may be low/moderate risk factors for ER-negative and TNBC subtypes of breast cancer.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Endocrinology & Metabolism

Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study

Wajd Alkabbani, Colleen J. J. Maxwell, Ruth Ann Marrie, Suzanne L. L. Tyas, Iliana C. C. Lega, John-Michael Gamble

Summary: This study reevaluates the association between insulin use and dementia risk in type 2 diabetes patients, considering confounding factors. The results showed no significant association between insulin use and all-cause dementia in patients previously treated with two noninsulin antihyperglycemic medications.

DIABETES CARE (2023)

Meeting Abstract Oncology

Double-edged soil: Stromal microenvironment in breast cancer development

Mustapha Abubakar, Shaoqi Fan, Maire A. Duggan, Ruth M. Pfeiffer, Scott Lawrence, Kathryn Richert-Boe, Andrew Glass, Teresa M. Kimes, Jonine D. Figueroa, Thomas E. Rohan, Gretchen L. Gierach

CANCER RESEARCH (2022)

Article Oncology

Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study

Ashley M. Geczik, Roni T. Falk, Xia Xu, Daniel Ansong, Joel Yarney, Beatrice Wiafe-Addai, Lawrence Edusei, Florence Dedey, Verna Vanderpuye, Nicholas Titiloye, Ernest Adjei, Francis Aitpillah, Ernest Osei-Bonsu, Joseph Oppong, Richard Biritwum, Kofi Nyarko, Seth Wiafe, Baffour Awuah, Joe-Nat Clegg-Lamptey, Thomas U. Ahearn, Jonine Figueroa, Montserrat Garcia-Closas, Louise A. Brinton, Britton Trabert

Summary: This study aimed to investigate the relationship between circulating estrogen levels and anthropometric measures in African women and their relevance to breast cancer risk factors. The results showed that measured BMI and WHR were positively associated with estrogen levels, similar to the relationship previously observed in postmenopausal White women at higher risk for breast cancer. However, height was not associated with estrogen levels in African women.

BREAST CANCER RESEARCH (2022)

Article Oncology

Common variants in breast cancer risk loci predispose to distinct tumor subtypes

Thomas U. Ahearn, Haoyu Zhang, Kyriaki Michailidou, Roger L. Milne, Manjeet K. Bolla, Joe Dennis, Alison M. Dunning, Michael Lush, Qin Wang, Irene L. Andrulis, Hoda Anton-Culver, Volker Arndt, Kristan J. Aronson, Paul L. Auer, Annelie Augustinsson, Adinda Baten, Heiko Becher, Sabine Behrens, Javier Benitez, Marina Bermisheva, Carl Blomqvist, Stig E. Bojesen, Bernardo Bonanni, Anne-Lise Borresen-Dale, Hiltrud Brauch, Hermann Brenner, Angela Brooks-Wilson, Thomas Bruening, Barbara Burwinkel, Saundra S. Buys, Federico Canzian, Jose E. Castelao, Jenny Chang-Claude, Stephen J. Chanock, Georgia Chenevix-Trench, Christine L. Clarke, J. Margriet Collee, Angela Cox, Simon S. Cross, Kamila Czene, Mary B. Daly, Peter Devilee, Thilo Dork, Miriam Dwek, Diana M. Eccles, D. Gareth Evans, Peter A. Fasching, Jonine Figueroa, Giuseppe Floris, Manuela Gago-Dominguez, Susan M. Gapstur, Jose A. Garcia-Saenz, Mia M. Gaudet, Graham G. Giles, Mark S. Goldberg, Anna Gonzalez-Neira, Grethe I. Grenaker Alnaes, Mervi Grip, Pascal Guenel, Christopher A. Haiman, Per Hall, Ute Hamann, Elaine F. Harkness, Bernadette A. M. Heemskerk-Gerritsen, Bernd Holleczek, Antoinette Hollestelle, Maartje J. Hooning, Robert N. Hoover, John L. Hopper, Anthony Howell, Milena Jakimovska, Anna Jakubowska, Esther M. John, Michael E. Jones, Audrey Jung, Rudolf Kaaks, Saila Kauppila, Renske Keeman, Elza Khusnutdinova, Cari M. Kitahara, Yon-Dschun Ko, Stella Koutros, Vessela N. Kristensen, Ute Kruger, Katerina Kubelka-Sabit, Allison W. Kurian, Kyriacos Kyriacou, Diether Lambrechts, Derrick G. Lee, Annika Lindblom, Martha Linet, Jolanta Lissowska, Ana Llaneza, Wing-Yee Lo, Robert J. MacInnis, Arto Mannermaa, Mehdi Manoochehri, Sara Margolin, Maria Elena Martinez, Catriona McLean, Alfons Meindl, Usha Menon, Heli Nevanlinna, William G. Newman, Jesse Nodora, Kenneth Offit, Hakan Olsson, Nick Orr, Tjoung-Won Park-Simon, Alpa Patel, Julian Peto, Guillermo Pita, Dijana Plaseska-Karanfilska, Ross Prentice, Kevin Punie, Katri Pylkas, Paolo Radice, Gad Rennert, Atocha Romero, Thomas Ruediger, Emmanouil Saloustros, Sarah Sampson, Dale P. Sandler, Elinor J. Sawyer, Rita K. Schmutzler, Minouk J. Schoemaker, Ben Schottker, Mark E. Sherman, Xiao-Ou Shu, Snezhana Smichkoska, Melissa C. Southey, John J. Spinelli, Anthony J. Swerdlow, Rulla M. Tamimi, William J. Tapper, Jack A. Taylor, Lauren R. Teras, Mary Beth Terry, Diana Torres, Melissa A. Troester, Celine M. Vachon, Carolien H. M. van Deurzen, Elke M. van Veen, Philippe Wagner, Clarice R. Weinberg, Camilla Wendt, Jelle Wesseling, Robert Winqvist, Alicja Wolk, Xiaohong R. Yang, Wei Zheng, Fergus J. Couch, Jacques Simard, Peter Kraft, Douglas F. Easton, Paul D. P. Pharoah, Marjanka K. Schmidt, Montserrat Garcia-Closas, Nilanjan Chatterjee

Summary: This study identifies breast cancer susceptibility variants that are associated with tumor features and intrinsic molecular subtypes, providing insights for subtype-specific risk prediction.

BREAST CANCER RESEARCH (2022)

No Data Available